Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findings.

Erro ME, Zelaya MV, Mendioroz M, Larumbe R, Ortega-Cubero S, Lanciego JL, Lladó A, Cabada T, Tuñón T, García-Bragado F, Luquin MR, Pastor P, Ferrer I.

J Neurol. 2019 Jun 12. doi: 10.1007/s00415-019-09414-w. [Epub ahead of print]

PMID:
31190169
2.

Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers.

Carmona-Abellan M, Gabilondo I, Murueta-Goyena A, Khurana V, Tijero B, Luquin MR, Acera M, Del Pino R, Gardeazabal J, Martínez-Valbuena I, Sanchez-Pernaute R, Gómez-Esteban JC.

Parkinsonism Relat Disord. 2019 Jun 5. pii: S1353-8020(19)30259-7. doi: 10.1016/j.parkreldis.2019.05.038. [Epub ahead of print]

PMID:
31178336
3.

Combining Gene Transfer and Nonhuman Primates to Better Understand and Treat Parkinson's Disease.

Lasbleiz C, Mestre-Francés N, Devau G, Luquin MR, Tenenbaum L, Kremer EJ, Verdier JM.

Front Mol Neurosci. 2019 Feb 11;12:10. doi: 10.3389/fnmol.2019.00010. eCollection 2019.

4.

Validation of a simple screening tool for early diagnosis of advanced Parkinson's disease in daily practice: the CDEPA questionnaire.

Martinez-Martin P, Kulisevsky J, Mir P, Tolosa E, García-Delgado P, Luquin MR.

NPJ Parkinsons Dis. 2018 Jul 2;4:20. doi: 10.1038/s41531-018-0056-2. eCollection 2018.

5.

The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia.

Rojo-Bustamante E, Abellanas MA, Clavero P, Thiolat ML, Li Q, Luquin MR, Bezard E, Aymerich MS.

Neurobiol Dis. 2018 Oct;118:64-75. doi: 10.1016/j.nbd.2018.06.019. Epub 2018 Jun 21.

PMID:
29936234
6.

Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.

Martinez-Valbuena I, Amat-Villegas I, Valenti-Azcarate R, Carmona-Abellan MDM, Marcilla I, Tuñon MT, Luquin MR.

Acta Neuropathol. 2018 Jun;135(6):877-886. doi: 10.1007/s00401-018-1832-0. Epub 2018 Mar 13.

PMID:
29536165
7.

[Myths and evidence on the use of botulinum toxin: neuropharmacology and dystonia].

Garcia-Ruiz PJ, Sanz-Cartagena P, Martinez-Castrillo JC, Ares-Pensado B, Aviles-Olmos I, Blazquez-Estrada M, Fanjul-Arbos S, Garcia-Caldentey J, Gazulla J, Gutierrez-Garcia J, Huete-Anton B, Lucas-Rodenas C, Luquin MR, Martinez-Torres I, Medialdea-Natera P, Mendoza-Rodriguez A, Mir-Rivera P, Posada IJ, Ruiz-Martinez J, Sanchez-Alonso P, Trejo-Gabriel Y Galan JM, Vela L, Pena-Segura JL.

Rev Neurol. 2018 Mar 1;66(5):163-172. Review. Spanish.

8.

Isolated palatal tremor as unique clinical manifestation of SCA 18 due to a new mutation of IFRD1.

Echeveste B, Covarrubias E, Cabello JP, Luquin MR.

Parkinsonism Relat Disord. 2017 Sep;42:100-101. doi: 10.1016/j.parkreldis.2017.05.026. Epub 2017 May 31. No abstract available.

PMID:
28601596
9.

Consensus on the Definition of Advanced Parkinson's Disease: A Neurologists-Based Delphi Study (CEPA Study).

Luquin MR, Kulisevsky J, Martinez-Martin P, Mir P, Tolosa ES.

Parkinsons Dis. 2017;2017:4047392. doi: 10.1155/2017/4047392. Epub 2017 Jan 23.

10.

Development and characterization of polo-like kinase 2 loaded nanoparticles-A novel strategy for (serine-129) phosphorylation of alpha-synuclein.

Rodríguez-Nogales C, Garbayo E, Martínez-Valbuena I, Sebastián V, Luquin MR, Blanco-Prieto MJ.

Int J Pharm. 2016 Nov 30;514(1):142-149. doi: 10.1016/j.ijpharm.2016.06.044.

PMID:
27863657
11.

Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys.

Garbayo E, Ansorena E, Lana H, Carmona-Abellan MD, Marcilla I, Lanciego JL, Luquin MR, Blanco-Prieto MJ.

Biomaterials. 2016 Dec;110:11-23. doi: 10.1016/j.biomaterials.2016.09.015. Epub 2016 Sep 21.

PMID:
27697668
12.

Brain aging and Parkinson's disease: New therapeutic approaches using drug delivery systems.

Rodríguez-Nogales C, Garbayo E, Carmona-Abellán MM, Luquin MR, Blanco-Prieto MJ.

Maturitas. 2016 Feb;84:25-31. doi: 10.1016/j.maturitas.2015.11.009. Epub 2015 Nov 21. Review.

13.

Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.

Zelaya MV, Pérez-Valderrama E, de Morentin XM, Tuñon T, Ferrer I, Luquin MR, Fernandez-Irigoyen J, Santamaría E.

Oncotarget. 2015 Nov 24;6(37):39437-56. doi: 10.18632/oncotarget.6254.

14.

Metabolic patterns in prion diseases: an FDG PET voxel-based analysis.

Prieto E, Domínguez-Prado I, Riverol M, Ortega-Cubero S, Ribelles MJ, Luquin MR, de Castro P, Arbizu J.

Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1522-9. doi: 10.1007/s00259-015-3090-x. Epub 2015 Jun 4.

PMID:
26041084
15.

[Neuropsychological profile of frontotemporal lobar degeneration].

Carmona-Abellán MM, Luquin MR, Lamet I, Pujol Giménez N, Esteve-Belloch P, Rivero M.

An Sist Sanit Navar. 2015 Jan-Apr;38(1):79-92. Review. Spanish.

16.

Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations.

Tijero B, Gabilondo I, Lezcano E, Teran-Villagrá N, Llorens V, Ruiz-Martinez J, Marti-Masso JF, Carmona M, Luquin MR, Berganzo K, Fernandez I, Fernandez M, Zarranz JJ, Gómez-Esteban JC.

Parkinsonism Relat Disord. 2015 Jul;21(7):717-22. doi: 10.1016/j.parkreldis.2015.04.012. Epub 2015 Apr 23.

PMID:
25960264
17.

Primary Whipple disease of the CNS presenting with chorea and dystonia: A video case report.

Palma JA, Luquin MR, Riverol M, Irimia P, Fernandez-Alonso M, Tejada J, Martinez-Vila E.

Neurol Clin Pract. 2014 Dec;4(6):508-510. doi: 10.1212/CPJ.0000000000000055. No abstract available.

18.

[Functional neuroimaging in the diagnosis of patients with Parkinsonism: Update and recommendations for clinical use].

Arbizu J, Luquin MR, Abella J, de la Fuente-Fernández R, Fernandez-Torrón R, García-Solís D, Garrastachu P, Jiménez-Hoyuela JM, Llaneza M, Lomeña F, Lorenzo-Bosquet C, Martí MJ, Martinez-Castrillo JC, Mir P, Mitjavila M, Ruiz-Martínez J, Vela L.

Rev Esp Med Nucl Imagen Mol. 2014 Jul-Aug;33(4):215-26. doi: 10.1016/j.remn.2014.02.001. Epub 2014 Apr 14. Review. Spanish.

19.

Sustained increase of PKA activity in the postcommissural putamen of dyskinetic monkeys.

Azkona G, Marcilla I, López de Maturana R, Sousa A, Pérez-Navarro E, Luquin MR, Sanchez-Pernaute R.

Mol Neurobiol. 2014 Dec;50(3):1131-41. doi: 10.1007/s12035-014-8688-7. Epub 2014 Apr 5.

PMID:
24705818
20.

The adult macaque spinal cord central canal zone contains proliferative cells and closely resembles the human.

Alfaro-Cervello C, Cebrian-Silla A, Soriano-Navarro M, Garcia-Tarraga P, Matías-Guiu J, Gomez-Pinedo U, Molina Aguilar P, Alvarez-Buylla A, Luquin MR, Garcia-Verdugo JM.

J Comp Neurol. 2014 Jun 1;522(8):1800-17. doi: 10.1002/cne.23501.

PMID:
24638933
21.

[Predictive factors of the response to treatment with onabotulinumtoxinA in refractory migraine].

Pagola I, Esteve-Belloch P, Palma JA, Luquin MR, Riverol M, Martinez-Vila E, Irimia P.

Rev Neurol. 2014 Mar 16;58(6):241-6. Spanish.

22.

Clinical and neuroimaging characteristics of 14 patients with prionopathy: a descriptive study.

Ortega-Cubero S, Pagola I, Luquin MR, Viteri C, Pastor P, Gállego Pérez-Larraya J, de Castro P, Domínguez I, Irimia P, Martínez-Vila E, Arbizu J, Riverol M.

Neurologia. 2015 Apr;30(3):144-52. doi: 10.1016/j.nrl.2013.12.004. Epub 2014 Feb 26. English, Spanish.

23.

Correction: Sox-2 Positive Neural Progenitors in the Primate Striatum Undergo Dynamic Changes after Dopamine Denervation.

Ordoñez C, Moreno-Murciano P, Hernandez M, Di Caudo C, Mundiñano IC, Vazquez N, Garcia-Verdugo JM, Sanchez-Pernaute R, Luquin MR.

PLoS One. 2013 Sep 20;8(9). doi: 10.1371/annotation/e844adbf-7acf-4b7a-8eaa-46e356c5d9f5. eCollection 2013.

24.

Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.

Riverol M, Ordóñez C, Collantes M, DiCaudo C, Peñuelas I, Arbizu J, Marcilla I, Luquin MR.

Neurobiol Dis. 2014 Feb;62:250-9. doi: 10.1016/j.nbd.2013.09.014. Epub 2013 Sep 27.

PMID:
24076099
25.

Modeling Parkinson's disease in monkeys for translational studies, a critical analysis.

Potts LF, Wu H, Singh A, Marcilla I, Luquin MR, Papa SM.

Exp Neurol. 2014 Jun;256:133-43. doi: 10.1016/j.expneurol.2013.09.014. Epub 2013 Sep 23. Review.

26.

Advanced Parkinson's disease: clinical characteristics and treatment. Part II.

Kulisevsky J, Luquin MR, Arbelo JM, Burguera JA, Carrillo F, Castro A, Chacón J, García-Ruiz PJ, Lezcano E, Mir P, Martinez-Castrillo JC, Martínez-Torres I, Puente V, Sesar A, Valldeoriola-Serra F, Yañez R.

Neurologia. 2013 Nov-Dec;28(9):558-83. doi: 10.1016/j.nrl.2013.05.002. Epub 2013 Jul 21. Review. English, Spanish.

27.

[Advanced Parkinson's disease: clinical characteristics and treatment (part 1)].

Kulisevsky J, Luquin MR, Arbelo JM, Burguera JA, Carrillo F, Castro A, Chacón J, García-Ruiz PJ, Lezcano E, Mir P, Martinez-Castrillo JC, Martínez-Torres I, Puente V, Sesar A, Valldeoriola-Serra F, Yañez R.

Neurologia. 2013 Oct;28(8):503-21. doi: 10.1016/j.nrl.2013.05.001. Epub 2013 Jul 13. Review. Spanish.

28.

Sox-2 Positive Neural Progenitors in the Primate Striatum Undergo Dynamic Changes after Dopamine Denervation.

Ordoñez C, Moreno-Murciano P, Hernandez M, Di Caudo C, Mundiñano IC, Carril-Mundiñano I, Vazquez N, Garcia-Verdugo JM, Sanchez-Pernaute R, Luquin MR.

PLoS One. 2013 Jun 18;8(6):e66377. doi: 10.1371/journal.pone.0066377. Print 2013. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/e844adbf-7acf-4b7a-8eaa-46e356c5d9f5. Carril-Mundiñano, Iñaki [corrected to Mundiñano, Iñaki-Carril].

29.

Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys.

Mundiñano IC, Hernandez M, Dicaudo C, Ordoñez C, Marcilla I, Tuñon MT, Luquin MR.

Acta Neuropathol. 2013 Sep;126(3):411-25. doi: 10.1007/s00401-013-1144-3. Epub 2013 Jun 20.

PMID:
23784261
30.

Is cardiac function impaired in premotor Parkinson's disease? A retrospective cohort study.

Palma JA, Carmona-Abellan MM, Barriobero N, Trevino-Peinado C, Garcia-Lopez M, Fernandez-Jarne E, Luquin MR.

Mov Disord. 2013 May;28(5):591-6. doi: 10.1002/mds.25431. Epub 2013 Mar 11.

PMID:
23483644
31.

Chronic levodopa administration followed by a washout period increased number and induced phenotypic changes in striatal dopaminergic cells in MPTP-monkeys.

DiCaudo C, Riverol M, Mundiñano IC, Ordoñez C, Hernández M, Marcilla I, Luquin MR.

PLoS One. 2012;7(11):e50842. doi: 10.1371/journal.pone.0050842. Epub 2012 Nov 30.

32.

[Levodopa in the treatment of Parkinson's disease: myths and realties].

Luquin MR, García-Ruiz PJ, Martí MJ, Rojo A, Vela L, Grandas FJ, Bravo-Utrera M, Burguera JA, Chacón JR, Campos-Arillo VM, Durán-Herrera C, Fernández-García JM, García-Ramos R, Gómez-Esteban JC, Gutierrez J, Juni J, Mata M, Martínez-Castrillo JC, Olivares J, Ribacoba-Montero R, Santos-García D, Sierra M, Valero-Merino C.

Rev Neurol. 2012 Dec 1;55(11):669-88. Review. Spanish.

33.

[Limits of conventional oral and transdermal medication in Parkinson's disease].

García-Ruiz PJ, Luquin MR.

Rev Neurol. 2012;55 Suppl 1:S3-6. Review. Spanish.

PMID:
23169231
34.

[Presentation].

García-Ruiz PJ, Luquin MR, Martínez-Castrillo JC.

Rev Neurol. 2012;55 Suppl 1:S1. Spanish. No abstract available.

PMID:
23169226
35.

[Clinical experience of treatment with onabotulinumtoxin A in patients with refractory migraine].

Palma JA, Irimia P, Fernandez-Torron R, Ortega-Cubero S, Riverol M, Luquin MR, Martinez-Vila E.

Rev Neurol. 2012 Jun 16;54(12):705-11. Spanish.

36.

LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation.

Lorenzo-Betancor O, Samaranch L, Ezquerra M, Tolosa E, Lorenzo E, Irigoyen J, Gaig C, Pastor MA, Soto-Ortolaza AI, Ross OA, Rodríguez-Oroz MC, Valldeoriola F, Martí MJ, Luquin MR, Perez-Tur J, Burguera JA, Obeso JA, Pastor P.

Mov Disord. 2012 Jan;27(1):146-51. doi: 10.1002/mds.23968. Epub 2011 Oct 28.

PMID:
22038903
37.

Structural and functional neuroimaging in human prion diseases.

Ortega-Cubero S, Luquín MR, Domínguez I, Arbizu J, Pagola I, Carmona-Abellán MM, Riverol M.

Neurologia. 2013 Jun;28(5):299-308. doi: 10.1016/j.nrl.2011.03.012. Epub 2011 May 31. Review. English, Spanish.

38.

Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.

Mundiñano IC, Caballero MC, Ordóñez C, Hernandez M, DiCaudo C, Marcilla I, Erro ME, Tuñon MT, Luquin MR.

Acta Neuropathol. 2011 Jul;122(1):61-74. doi: 10.1007/s00401-011-0830-2. Epub 2011 May 8.

PMID:
21553300
39.

Variant Creutzfeldt-Jakob disease occurring in mother and son.

Riverol M, Palma JA, Alañá M, Guerrero-Márquez C, Luquin MR, Rábano A.

J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):235-6. doi: 10.1136/jnnp.2010.232074. Epub 2011 Jan 21. No abstract available.

PMID:
21257982
40.

Enhanced GDNF expression in dopaminergic cells of monkeys grafted with carotid body cell aggregates.

Luquin MR, Manrique M, Guillén J, Arbizu J, Ordoñez C, Marcilla I.

Brain Res. 2011 Feb 23;1375:120-7. doi: 10.1016/j.brainres.2010.12.033. Epub 2010 Dec 17.

PMID:
21168394
41.

Analysis of the GIGYF2 gene in familial and sporadic Parkinson disease in the Spanish population.

Samaranch L, Lorenzo E, Pastor MA, Riverol M, Luquin MR, Rodríguez-Oroz MC, Obeso JA, Pastor P.

Eur J Neurol. 2010 Feb;17(2):321-5. doi: 10.1111/j.1468-1331.2009.02812.x. Epub 2009 Oct 21.

PMID:
19845746
42.

Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys.

Vázquez-Claverie M, Garrido-Gil P, San Sebastián W, Izal-Azcárate A, Belzunegui S, Marcilla I, López B, Luquin MR.

J Neuropathol Exp Neurol. 2009 Sep;68(9):977-84. doi: 10.1097/NEN.0b013e3181b35e41.

PMID:
19680145
43.

Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication.

Rolland AS, Tandé D, Herrero MT, Luquin MR, Vazquez-Claverie M, Karachi C, Hirsch EC, François C.

J Neurochem. 2009 Aug;110(4):1321-9. doi: 10.1111/j.1471-4159.2009.06220.x. Epub 2009 Jun 12.

44.

New MRI, 18F-DOPA and 11C-(+)-alpha-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: advantages to improve PET quantification.

Collantes M, Prieto E, Peñuelas I, Blesa J, Juri C, Martí-Climent JM, Quincoces G, Arbizu J, Riverol M, Zubieta JL, Rodriguez-Oroz MC, Luquin MR, Richter JA, Obeso JA.

Neuroimage. 2009 Aug 15;47(2):533-9. doi: 10.1016/j.neuroimage.2009.04.078. Epub 2009 May 5.

PMID:
19422919
45.

Isolation, culture and characterization of adult carotid body-derived cells.

Izal-Azcárate A, Gutiérrez-Pérez M, Izal I, Belzunegui S, Sebastián WS, López B, Marcilla I, Prósper F, Luquin MR.

Respir Physiol Neurobiol. 2009 Jun 30;167(2):201-7. doi: 10.1016/j.resp.2009.04.021. Epub 2009 May 3.

46.

Ultrastructure of the subventricular zone in Macaca fascicularis and evidence of a mouse-like migratory stream.

Gil-Perotin S, Duran-Moreno M, Belzunegui S, Luquin MR, Garcia-Verdugo JM.

J Comp Neurol. 2009 Jun 10;514(5):533-54. doi: 10.1002/cne.22026.

PMID:
19350672
47.

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not elicit long-lasting increases in cyclooxygenase-2 expression in dopaminergic neurons of monkeys.

Vázquez-Claverie M, Garrido-Gil P, San Sebastián W, Belzunegui S, Izal-Azcárate A, López B, Marcilla I, Luquin MR.

J Neuropathol Exp Neurol. 2009 Jan;68(1):26-36. doi: 10.1097/NEN.0b013e3181919275.

PMID:
19104449
48.

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys.

Garrido-Gil P, Belzunegui S, San Sebastián W, Izal-Azcárate A, López B, Marcilla I, Luquin MR.

J Neurosci Res. 2009 Feb;87(2):586-97. doi: 10.1002/jnr.21845.

PMID:
18798285
49.

Striatal carotid body graft promotes differentiation of neural progenitor cells into neurons in the olfactory bulb of adult hemiparkisonian rats.

Belzunegui S, Izal-Azcárate A, San Sebastián W, Garrido-Gil P, Vázquez-Claverie M, López B, Marcilla I, Luquin MR.

Brain Res. 2008 Jun 27;1217:213-20. doi: 10.1016/j.brainres.2008.04.015. Epub 2008 Apr 16.

PMID:
18502401
50.

The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP.

Belzunegui S, San Sebastián W, Garrido-Gil P, Izal-Azcárate A, Vázquez-Claverie M, López B, Marcilla I, Lanciego JL, Luquin MR.

Synapse. 2007 Dec;61(12):1006-12.

Supplemental Content

Loading ...
Support Center